Startseite Neonatal Goiter Caused by Expectorant Usage
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Neonatal Goiter Caused by Expectorant Usage

  • Ilknur Bostancı EMAIL logo , Akile Sanoglu , Hacer Ergin , Arif Akşit , Mine Cinbiş und Necdet Aklın
Veröffentlicht/Copyright: 11. Oktober 2016

Abstract

A female newborn was admitted with the symptoms of mild respiratory distress, protruding tongue, hypotonicity, cutis marmorata, sclerema, myxedema, abdominal distension, and feeding problems on the first day of life. She had a huge neck mass, a large anterior and posterior fontanel, and hoarse cry. She had no umbilical hernia or jaundice. A history of maternal potassium iodine (expectorant) usage without doctor’s advice was obtained; the mother had not attended a clinic throughout the pregnancy. On ultrasonographic examination, the thyroid right lobe was 53x31 mm and the left lobe was 34x31 mm. The results of thyroid hormone tests on the first day were as follows: T3 20 ng/dl (normal: 32-216 ng/dl), T4 0.9 μg/dl (11.8-22.6 μg/dl), TSH 120 mIU/1 (2.5-13.3 mIU/1). This patient is presented to emphasize the role of hypothyroidism in drug-induced neonatal goiter and to discuss the possibility of a life-threatening effect of congenital goiter, i.e. respiratory tract obstruction.

Published Online: 2016-10-11
Published in Print: 2001-9-1

© 2016 by Walter de Gruyter Berlin/Boston

Artikel in diesem Heft

  1. Titelei
  2. Table of Contents
  3. Doping with Growth Hormone
  4. Intrauterine Diabetic Environment Confers Risks for Type 2 Diabetes Mellitus and Obesity in the Offspring, in Addition to Genetic Susceptibility
  5. Variable Presentation of X-linked Adrenal Hypoplasia Congenita
  6. Sustained Benefits of Growth Hormone on Body Composition, Fat Utilization, Physical Strength and Agility, and Growth in Prader-Willi Syndrome are Dose-Dependent
  7. Insufficient Adrenarche in Patients with Combined Pituitary Hormone Deficiency Caused by a PROP A Gene Defect
  8. Syndrome of Congenital Adrenocortical Unresponsiveness to ACTH. Report of Six Patients
  9. Maternal and Fetal Serum Insulin-like Growth Factor-I (IGF-I), IGF Binding Protein-3 (IGFBP-3), Leptin Levels and Early Postnatal Growth in Infants Born Asymmetrically Small for Gestational Age
  10. Relationships Between Levels of Leptin and Hematological Parameters in Healthy Term Infants
  11. Recombinant Growth Hormone Treatment in Short Patients with Thalassemia Major: Results after 24 and 36 Months
  12. Assessment of the Current Status of Iodine Prophylaxis in Bosnia and Herzegovina Federation
  13. Profiles of Obese Children Presenting for Metabolic Evaluation
  14. Effect of Growth Hormone Treatment on Hypoglycemia in a Patient with both Hepatic Glycogen Synthase and Isolated Growth Hormone Deficiencies
  15. Gliclazide-Induced Hepatitis, Hemiplegia and Dysphasia in a Suicide Attempt
  16. Neonatal Goiter Caused by Expectorant Usage
  17. Idiopathic Hypothalamic Dysfunction with Precocious Puberty and Adipsic Hypernatremia First Presenting in Adolescence
  18. Neonatal Hyperthyroidism m Infants of Mothers Previously Thyroidectomized due to Graves’ Disease
  19. Primary Hyperparathyroidism in an Infant with Three Parathyroid Glands and Pulmonary Calcinosis
  20. Asymmetric Crying Facies and Congenital Hypothyroidism: Report of Two Patients
  21. Obituary. Professor Dr. Andrea Prader (1919–2001)
  22. Meetings Calendar
  23. Author Index
Heruntergeladen am 21.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2001-0815/html
Button zum nach oben scrollen